Imagine an all-in-one device that gives risk indicators for 16+ important diseases in under two minutes, with high accuracy thanks to AI, an all-in-one preventive health check at one-tenth of the cost. We have what you need.
We are the official international distributor for a Singapore AI-based company. Backed by over US $100 million in government funding and ten years of research, its technology detects risk indications for diabetes, cardiovascular & stroke disease with 10-year risk, chronic kidney disease, hypertension, dementia, cataract, glaucoma, age-related macular degeneration and more, within seconds.
Every figure below is backed by peer-reviewed research published in leading journals.
Predicts stroke risk up to ten years in advance.
Publication available late 2026
In validation β risk indication for dementia.
Publication available late 2026
Risk indication for hypertension β published within the Diabetes study.
Read the studyIn validation β risk indication for hyperlipidemia.
Publication available late 2026Risk indication for fatty liver disease.
Publication available late 2026
Screening for the leading cause of preventable blindness.
Read the study
Early AMD risk indication from retinal imaging.
Read the studyToo many people discover their status only at an advanced stage. Bringing cancer risk indication to a simple eye scan is a top priority on the platform's roadmap. Subject to R&D progress and funding.
Accelerated biological age β where internal physiological wear outpaces chronological time β indicates a significantly higher risk for chronic illnesses, early-onset solid cancers, cardiovascular disease, cognitive decline, dementia and all-cause mortality compared to peers of the same calendar age.
The world believed AI would transform healthcare in the next decade. It was built for today. With a single eye scan, early detection can reach millions worldwide right now.
One eye scan can change a life forever. Let's bring early detection to millions, together.
Contact us